| Date Filed | Type | Description |
| 11/18/2022 |
4
| Thomsen Jillian B. (CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 11,095 shares
@ $3.57, valued at
$39.6k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 2,363 shares
@ $10.95, valued at
$25.9k
|
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 14,900 shares
@ $0
Sold 6,741 shares
@ $13.16, valued at
$88.7k
|
|
| 10/14/2021 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 26,600 options to buy
@ $21.79, valued at
$579.6k
|
|
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 75,000 shares
@ $18.62, valued at
$1.4M
Exercised 37,500 options to buy
@ $8.8, valued at
$330k
|
|
| 12/22/2020 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 16,000 shares
@ $0
Granted 28,600 options
@ $18.75, valued at
$536.3k
|
|
| 11/18/2020 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 11,976 shares
@ $16.93, valued at
$202.8k
|
|
| 08/19/2020 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 1,367 shares
@ $19.67, valued at
$26.9k
|
|
| 05/20/2020 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 1,367 shares
@ $22.51, valued at
$30.8k
|
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 37,500 shares
@ $22.78, valued at
$854.3k
Exercised 37,500 options to buy
@ $7.21, valued at
$270.4k
|
|
| 12/16/2019 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 14,900 shares
@ $0
Granted 26,600 options
@ $21.79, valued at
$579.6k
Granted 11,800 options
@ $21.79, valued at
$257.1k
|
|
| 11/20/2019 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 2,713 shares
@ $17.97, valued at
$48.8k
|
|
| 08/19/2019 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 1,809 shares
@ $18.15, valued at
$32.8k
|
|
| 05/17/2019 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 1,928 shares
@ $31.37, valued at
$60.5k
|
|
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2018 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 10,950 shares
@ $0
Granted 22,150 options
@ $36.51, valued at
$808.7k
|
|
| 11/19/2018 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 4,016 shares
@ $38.25, valued at
$153.6k
|
|
| 11/05/2018 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 90,000 shares
@ $0 |
|
| 08/16/2018 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 10,400 shares
@ $0
Disposed/sold 4,883 shares
@ $58.4, valued at
$285.2k
Granted 26,250 options to buy
@ $56.9, valued at
$1.5M
|
|
| 05/18/2018 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 3,576 shares
@ $83.39, valued at
$298.2k
|
|
| 04/18/2018 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 13,881 shares
@ $101.46, valued at
$1.4M
Exercised 13,881 options to buy
@ $10.69, valued at
$148.4k
|
|
| 02/20/2018 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 2,545 shares
@ $82.94, valued at
$211.1k
|
|
| 12/19/2017 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 10,400 shares
@ $0
Granted 26,250 options
@ $56.9, valued at
$1.5M
|
|
| 11/17/2017 |
4
| Thomsen Jillian B. (SVP & Chief Accounting Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 15,000 shares
@ $0
Disposed/sold 5,289 shares
@ $44.23, valued at
$233.9k
Granted 37,500 options to buy
@ $14.41, valued at
$540.4k
|
|
| 08/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|